Healing and prevention of NSAID-associated ulcer disease: is seeing believing?
Fendrick
A M
AM
Division of General Medicine, University of Michigan Medical Center, Ann Arbor, USA.
Scheiman
J M
JM
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004724:Endoscopy; D006801:Humans; D016595:Misoprostol / Q000627:therapeutic use*; D009853:Omeprazole / Q000627:therapeutic use*; D011899:Ranitidine / Q000627:therapeutic use*; D055502:Secondary Prevention; D014456:Ulcer / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D014945:Wound Healing / Q000502:physiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D016595:Misoprostol; D011899:Ranitidine; D009853:Omeprazole